Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalfampridine and Physical Therapy in Non-Ambulatory MS
NCT05859802Phase 3Completed
- Sponsor
- D'Youville University
- Start
- Jul 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of dalfampridine in multiple sclerosis (MS), sponsored by D'Youville University. Started Jul 2011; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT05859802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05859802.